OREGA BIOTECH

Orega Biotech is a biotech company committed to the development of immunotherapeutics for the treatment of cancer. Backed by INSERM-Transfert and OCTALFA, Orega Biotech was set up in March 2010 at the initiative of its four founders bringing together scientific and business skills. The company specializes in the development of monoclonal antibodies for cancer immunotherapy. Focusing on tumor microenvironment, the company's target discovery program aims at discovering and validating novel clinically-relevant cancer targets. Orega Biotech is headquartered in Écully, France.